NDC product
Obagi Skintrinsiq Clarifiying Protocol
NDC 62032-909 · Obagi Cosmeceuticals LLC
Key facts
| Product NDC | 62032-909 |
|---|---|
| Proprietary name | Obagi Skintrinsiq Clarifiying Protocol |
| Nonproprietary name | salicylic acid, titanium dioxide, and zinc oxide |
| Dosage form | KIT |
| Labeler | Obagi Cosmeceuticals LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M020 |
| Marketing start | Aug 1, 2021 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: